LSTA
Closed
Lisata Therapeutics Inc.
2.86
-0.04 (-1.38%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 2.8991
Day's Range: 2.82 - 2.93
Send
sign up or login to leave a comment!
When Written:
3.08
Lisata Therapeutics Inc. is a biotechnology company that focuses on developing novel gene therapies for the treatment of inherited diseases. The company was founded in 2016 and is headquartered in Vancouver, Canada. Lisata's gene therapy platform is based on a proprietary technology called CRISPR/Cas9, which allows for precise editing of genetic material. The company's lead program is focused on developing a gene therapy for the treatment of beta-thalassemia, a genetic blood disorder. Lisata is also exploring the potential of its gene therapy platform in other disease areas, including sickle cell disease and cystic fibrosis.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








